相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure-guided changes at the V2 apex of HIV-1 Glade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies
Anusmita Sahoo et al.
CELL REPORTS (2022)
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Mads Delbo Larsen et al.
SCIENCE (2021)
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
Tysheena P. Charles et al.
PLOS PATHOGENS (2021)
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge
Delphine C. Malherbe et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
Ayan Dey et al.
VACCINE (2021)
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
Prabhu S. Arunachalam et al.
NATURE MEDICINE (2020)
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om et al.
PLOS PATHOGENS (2020)
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound
Rasmus Offersen et al.
CELL REPORTS (2020)
CD8+ T cells in HIV control, cure and prevention
David R. Collins et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases
Edward B. Irvine et al.
GLYCOBIOLOGY (2020)
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
Andrew T. Jones et al.
NATURE COMMUNICATIONS (2019)
A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis
Christina B. Karsten et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge
Tiffany M. Styles et al.
JOURNAL OF VIROLOGY (2019)
Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV
Susan Zolla-Pazner et al.
CURRENT OPINION IN HIV AND AIDS (2019)
Circulating CXCR3+ Tfh cells positively correlate with neutralizing antibody responses in HCV-infected patients
Jian Zhang et al.
SCIENTIFIC REPORTS (2019)
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design (vol 25, pg 59, 2019)
Christine A. Bricault et al.
CELL HOST & MICROBE (2019)
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers
Ralf Duerr et al.
VACCINES (2019)
Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy
Venkateswarlu Chamcha et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants
Samantha Burton et al.
JOURNAL OF VIROLOGY (2019)
A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization
David Bernstein et al.
VACCINE (2019)
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
Luca Schifanella et al.
PLOS PATHOGENS (2019)
Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques
Caroline Petitdemange et al.
JCI INSIGHT (2019)
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques
Andrew T. Jones et al.
JOURNAL OF VIROLOGY (2018)
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
Nicole L. Yates et al.
JOURNAL OF VIROLOGY (2018)
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
Martin R. Gaudinski et al.
LANCET (2018)
Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques
Yongjun Sui et al.
MUCOSAL IMMUNOLOGY (2018)
Antibody glycosylation in inflammation, disease and vaccination
Galit Alter et al.
SEMINARS IN IMMUNOLOGY (2018)
Structure-Guided Redesign Improves NFL HIV Env Trimer Integrity and Identifies an Inter-Protomer Disulfide Permitting Post-Expression Cleavage
Lifei Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunoglobulin G glycosylation in aging and diseases
Ivan Gudelja et al.
CELLULAR IMMUNOLOGY (2018)
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
Margaret E. Ackerman et al.
NATURE MEDICINE (2018)
The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
John D. Clements et al.
MSPHERE (2018)
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
Giuseppe Lofano et al.
SCIENCE IMMUNOLOGY (2018)
Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies
Sannula Kesavardhana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Mucosal IgA Responses: Damaged in Established HIV Infection - Yet, Effective Weapon against HIV Transmission
Viraj Kulkarni et al.
FRONTIERS IN IMMUNOLOGY (2017)
Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth
Enrique Martin-Gayo et al.
JCI INSIGHT (2017)
Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique
Colin Havenar-Daughton et al.
JOURNAL OF IMMUNOLOGY (2016)
Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques
Smita S. Iyer et al.
JOURNAL OF VIROLOGY (2016)
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Monica Vaccari et al.
NATURE MEDICINE (2016)
Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low-and Middle-Income Countries
Thomas M. Harmon et al.
PLOS ONE (2016)
Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Alison E. Mahan et al.
PLOS PATHOGENS (2016)
Fc glycans of therapeutic antibodies as critical quality attributes
Dietmar Reusch et al.
GLYCOBIOLOGY (2015)
Integrin α4β7 Expression Increases HIV Susceptibility in Activated Cervical CD4+ T Cells by an HIV Attachment-Independent Mechanism
Jian Ding et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis
Alison E. Mahan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques
Smita S. Iyer et al.
JOURNAL OF IMMUNOLOGY (2015)
Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope
Katie M. Kilgore et al.
JOURNAL OF VIROLOGY (2015)
Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses
Samantha L. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immune correlates of vaccine protection against HIV-1 acquisition
Lawrence Corey et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques
Diane G. Carnathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Needle free injection technology: A complete insight
Ansh Dev Ravi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION (2015)
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
Mario Roederer et al.
NATURE (2014)
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
Susan Zolla-Pazner et al.
PLOS ONE (2014)
Cryptic Determinant of alpha 4 beta 7 Binding in the V2 Loop of HIV-1 gp120
Boonrat Tassaneetrithep et al.
PLOS ONE (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Margaret E. Ackerman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
Susan Zolla-Pazner et al.
PLOS ONE (2013)
Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination
Salah-Eddine Bentebibel et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
Jean-Philippe Julien et al.
PLOS PATHOGENS (2013)
Designed Cyclic Permutants of HIV-1 gp120: Implications for Envelope Trimer Structure and Immunogen Design
Piyali Saha et al.
BIOCHEMISTRY (2012)
A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1-or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays
Michael D. Alpert et al.
JOURNAL OF VIROLOGY (2012)
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch et al.
NATURE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cytoscape 2.8: new features for data integration and network visualization
Michael E. Smoot et al.
BIOINFORMATICS (2011)
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Margaret E. Ackerman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
Paul A. Goepfert et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
Lilin Lai et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Assessing Vaccine Effects in Repeated Low-Dose Challenge Experiments
Michael G. Hudgens et al.
BIOMETRICS (2009)
Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
Anna Maria Geretti et al.
CLINICAL INFECTIOUS DISEASES (2009)
Appion: An integrated, database-driven pipeline to facilitate EM image processing
Gabriel C. Lander et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut
C. Wang et al.
MUCOSAL IMMUNOLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality
Bernard J. Scallon et al.
MOLECULAR IMMUNOLOGY (2007)
Molecularly cloned SHIV-1157ipd3N4:: a highly replication-competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C env
R. J. Song et al.
JOURNAL OF VIROLOGY (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Multiprotein HIV type 1 clade B DNA and MVA vaccines: Construction, expression, and immunogenicity in rodents of the MVA component
LS Wyatt et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Topology representing network enables highly accurate classification of protein images taken by cryo electron-microscope without masking
T Ogura et al.
JOURNAL OF STRUCTURAL BIOLOGY (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV
Y Enose et al.
VIROLOGY (2002)
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
RR Amara et al.
VACCINE (2002)
Antibody avidity and immunoglobulin G Isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine
CL Vermont et al.
INFECTION AND IMMUNITY (2002)
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques
IM Belyakov et al.
NATURE MEDICINE (2001)
分享论文
